Recent advances in ocular graft-versus-host disease

被引:13
|
作者
Cheng, Xianjing [1 ,2 ]
Huang, Ruihao [1 ]
Huang, Shiqin [1 ]
Fan, Wei [3 ]
Yuan, Rongdi [3 ]
Wang, Xiaoqi [1 ]
Zhang, Xi [1 ,2 ,4 ]
机构
[1] Army Med Univ, Xinqiao Hosp, State Key Lab Trauma Burns & Combined Injury, Med Ctr Hematol, Chongqing, Peoples R China
[2] Chongqing Univ, Sch Med, Chongqing, Peoples R China
[3] Army Med Univ, Xinqiao Hosp, Dept Ophthalmol, Chongqing, Peoples R China
[4] Jinfeng Lab, Chongqing, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
ocular graft-versus-host-disease; clinical characteristics; the pathogenic mechanism; novel therapeutic targets; tear biomarkers; STEM-CELL TRANSPLANTATION; SERUM EYE DROPS; CONSENSUS DEVELOPMENT PROJECT; MEIBOMIAN GLAND DYSFUNCTION; MESENCHYMAL STROMAL CELLS; DRY EYE; LACRIMAL GLAND; CLINICAL-TRIALS; LONGITUDINAL ANALYSIS; RANDOMIZED-TRIAL;
D O I
10.3389/fimmu.2023.1092108
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ocular graft-versus-host-disease (GVHD) remains a significant clinical complication after allogeneic hematopoietic stem cell transplantation. Impaired visual function, pain, and other symptoms severely affect affected individuals' quality of life. However, the diagnosis of and therapy for ocular GVHD involve a multidisciplinary approach and remain challenging for both hematologists and ophthalmologists, as there are no unified international criteria. Through an exploration of the complex pathogenesis of ocular GVHD, this review comprehensively summarizes the pathogenic mechanism, related tear biomarkers, and clinical characteristics of this disease. Novel therapies based on the mechanisms are also discussed to provide insights into the ocular GVHD treatment.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Current Concepts and Advances in Graft-Versus-Host Disease Immunology
    Hill, Geoffrey R.
    Betts, Brian C.
    Tkachev, Victor
    Kean, Leslie S.
    Blazar, Bruce R.
    ANNUAL REVIEW OF IMMUNOLOGY, VOL 39, 2021, 39 : 19 - 49
  • [32] Current issues in chronic graft-versus-host disease
    Socie, Gerard
    Ritz, Jerome
    BLOOD, 2014, 124 (03) : 374 - 384
  • [33] Current insights into ocular graft-versus-host disease
    Riemens, Anjo
    Boome, Liane Te
    Imhof, Saskia
    Kuball, Jurgen
    Rothova, Aniki
    CURRENT OPINION IN OPHTHALMOLOGY, 2010, 21 (06) : 485 - 494
  • [34] A brief account on ocular graft versus host disease
    Chatterjee, Debapriya
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (04) : 1115 - 1122
  • [35] Tear Osmolarity in Ocular Graft-Versus-Host Disease
    Berchicci, Luigi
    Iuliano, Lorenzo
    Miserocchi, Elisabetta
    Bandello, Francesco
    Modorati, Giulio
    CORNEA, 2014, 33 (12) : 1252 - 1256
  • [36] Ocular Graft-Versus-Host Disease Topic Review
    Hazem M Mousa
    Christopher E Starr
    Matias Soifer
    Christian Savarain
    Victor L Perez
    Current Ophthalmology Reports, 2020, 8 : 36 - 43
  • [37] Graft-versus-host disease
    Moreno, David F.
    Cid, Joan
    MEDICINA CLINICA, 2019, 152 (01): : 22 - 28
  • [38] Graft-versus-host disease
    Ferrara, James L. M.
    Levine, John E.
    Reddy, Pavan
    Holler, Ernst
    LANCET, 2009, 373 (9674) : 1550 - 1561
  • [39] Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD)
    Hu, Bohao
    Qiu, Yuan
    Hong, Jing
    OCULAR SURFACE, 2020, 18 (02) : 298 - 304
  • [40] Treatment of Ocular Graft-Versus-Host Disease With Topical Cyclosporine 0.05%
    Malta, Joao Baptista
    Soong, H. Kaz
    Shtein, Roni M.
    Musch, David C.
    Rhoades, William
    Sugar, Alan
    Mian, Shahzad I.
    CORNEA, 2010, 29 (12) : 1392 - 1396